Close

Concert Pharma (CNCE) Tops Q2 EPS by 3c

August 9, 2016 8:15 AM EDT

Concert Pharma (NASDAQ: CNCE) reported Q2 EPS of ($0.60), $0.03 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $71 thousand versus the consensus estimate of $30 thousand.

For earnings history and earnings-related data on Concert Pharma (CNCE) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings